Have questions for OurPharma?

Would you like more information regarding a product? Are you interested in a site visit to our headquarters? Contact our customer service team and we will respond within one business day.

Fill out the form and we will get back to you as soon as we can.

    Our Pharma Pharmaceuticals | Fayetteville Arkansas

    Headquarters:

    2512 S. City Lake Rd.
    Fayetteville, AR 72701

    Frequently Asked Questions

    To setup an account, please contact OurPharma’s Customer Service team at 479-313-8200 for a New Customer Application form. Once received, our team will reach out to request any additional information required.

    OurPharma maintains a portfolio of sterile, ready-to-administer CII controlled substances including cassettes, injectables and intravenous fluids.

    OurPharma is currently licensed in 10 states: Arkansas, Oklahoma, Kansas, Louisiana, Kentucky, Texas, Illinois, Missouri, Pennsylvania and Rhode Island.

    At OurPharma, we are committed to providing high quality medications, ensuring that Quality is built into every single step of the process.

    • Extensive employee Training Program
    • Vendor Qualification Program
    • Incoming Inspection of Production Materials
    • Robust Internal Audit Program
    • CAPA, deviation and Change Control Procedures
    • State of the art Cleanroom designed for maximum cross contamination prevention
    • Validated Processes and Systems
    • Extensive Cleanroom and Material Sanitization Programs
    • Advanced continuous Environmental Monitoring System
    • Robust Environmental Monitoring and Personnel Monitoring Programs
    • 100% Post Production Visual Inspection process
    • Third Party Batch Release Testing completed by an FDA registered contract laboratory
    • No Products are released until they are found to meet required specifications

    Each batch of drug product is evaluated by sampling units from the beginning, middle, and end of the batch using the appropriate release testing per FDA guidance. Our release testing is performed using validated methods and includes but may not be limited to: Identity & strength (Assay) of the API, Purity of the Drug Product, Sterility, Bacterial Endotoxin Levels, Color & Clarity, pH, in-process Bioburden, and Visible and Sub-visible Particles.

    Each drug product undergoes a data-driven stability study to determine its shelf life and corresponding finished product Expiration Date. We contract with third-party laboratories who use validated, stability indicating methods to test and analyze the Identity & Strength (Assay), Sterility, Endotoxin, Particulate, Appearance, pH, and Container Closure Integrity (CCIT) of the product over predetermined time points to determine a final product shelf life.

    No, our current catalog only consists of finished drug products requiring storage at controlled room temperature (20 – 25C). Our catalog may be updated in the future to include refrigerated items based on drug development and product offerings.

    We adhere to FDA’s 21 CFR Parts 210 & 211 , FDA 503B Guidance Document(s), DEA Rules and Regulations, and the State Board of Pharmacy Rules & Regulations for all states we are licensed in.

    We utilize both FDA approved finished drug products and FDA approved bulk API as starting materials in our compounding and manufacturing process.

    The training program for pharmacists and aseptic specialists (sterile pharmacy technicians) is a robust program that requires SOP reviews, on-the-job training & qualifications, personnel media fill qualifications, and didactic learning/exams. In addition to these training requirements, there is an ongoing effort to provide our staff with learning opportunities to acquire further knowledge and, in some cases, certifications specific to sterile compounding, quality systems, and current Good Manufacturing Practices (cGMP).

    To report a customer complaint, please reach out to OurPharma’s Customer Service Team at 479-313-8200.

    In addition to making a customer complaint, adverse events may also be reported to the FDA, either by making a submission online at fda.gov/medwatch or by phone at 1-800-FDA-1088.

    Place an Order